-
公开(公告)号:US20220185774A1
公开(公告)日:2022-06-16
申请号:US17425701
申请日:2019-09-27
发明人: Yinsheng ZHANG , Wangwei AO , Yuan LI , Hui WANG , Hangzhou SHEN , Jie NI , Huan ZHANG , Jie WU , Li ZHANG , Kai CAO , Peng LU , Xushi LIU , Jie WANG , Tianxiao ZHAO , Xingfeng GE , Dandan LU , Shuo CHEN , Xueqin MA , Wei SHI , Xiaojin WANG , Hongjiang XU
IPC分类号: C07D207/34 , A61P31/20
摘要: Provided is a compound of formula I or II, a stereoisomer, a tautomer, a geometrical isomer, a solvate, an active metabolite, a hydrate, a prodrug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof, and the medical uses thereof in treating diseases benefiting from the capsid protein assembly inhibitor, particularly diseases caused by hepatitis B virus infection.
-
公开(公告)号:US20210017154A1
公开(公告)日:2021-01-21
申请号:US17043593
申请日:2019-03-29
发明人: Yinsheng ZHANG , Wangwei AO , Yuan LI , Hui WANG , Hangzhou SHEN , Jie NI , Huan ZHANG , Jie WU , Li ZHANG , Kai CAO , Peng LU , Xushi LIU , Jie WANG , Tianxiao ZHAO , Xingfeng GE , Dandan LU , Shuo CHEN , Xueqin MA , Wei SHI , Xiaojin WANG , Hongjiang XU
IPC分类号: C07D401/12 , C07D207/34 , C07D405/12 , C07D409/12
摘要: A N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, and a pharmaceutical composition and use thereof, specifically relating to a compound as represented by formula I, a stereoisomer, a tautomer, a geometrical isomer, a solvate, an active metabolite, a hydrate, a prodrug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof, and a medical use thereof. The medical use comprises the use in treating diseases benefiting from the capsid protein assembly inhibitor, and in particular, diseases caused by hepatitis B virus infection.
-